🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Nuvalent appoints new independent director

Published 10/12/2024, 02:54 am
NUVL
-

Nuvalent, Inc. (NASDAQ:NUVL), a pharmaceutical company, has announced the appointment of Grant Bogle as an independent director to its board, effective immediately as of Monday. Bogle was elected to serve until the company's 2025 annual meeting of stockholders.

Bogle's appointment follows the company's policies and procedures for board membership, including a review by the Nominating and Corporate Governance Committee. He will be a Class I director and is considered independent according to Nasdaq rules.

As a non-employee director, Bogle will receive compensation in line with Nuvalent's established policy. This includes an initial stock option grant to purchase 4,851 shares of Nuvalent's Class A common stock at $93.73 per share and a restricted stock unit grant for 3,200 shares. These grants will vest over three years, contingent upon his continued service. Additionally, Bogle will receive annual cash retainers and may receive extra compensation for serving on board committees.

In a related development, Nuvalent's board approved a new form of award agreement for restricted stock units with performance-based vesting under the company's 2021 Stock Option and Incentive Plan.

The news above is based on an SEC filing.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.